Emergent Biosolutions Inc
Lobbying group · Jul 2025 – Sep 2026
Emergent Biosolutions Inc spent $2.2M lobbying the federal government (Jul 2025 – Sep 2026), mostly on health care, budget & spending, homeland security. It used 3 lobbyists, including people who worked for 1 members of Congress.
- Spent on lobbying
- $2.2M
- Lobbyists
- 3
- Bills lobbied
- 6
- Issues
- 6
Spending by quarter
- 2025 Q3$530K
- 2025 Q4$430K
- 2026 Q1$730K
- 2026 Q2$510K
Issues lobbied
- Health care
- Budget & spending
- Homeland security
- Disasters & emergencies
- Defense
- Aviation & airlines
Bills lobbied on
- H.R. 52529 reports
- H.R. 1968: Full-Year Continuing Appropriations and Extensions Act, 20255 reports
- H.R. 2483: SUPPORT for Patients and Communities Reauthorization Act of 20255 reports
- H.R. 8800: National Defense Authorization Act for Fiscal Year 20273 reports
- S. 4784: National Defense Authorization Act for Fiscal Year 20273 reports
- H.R. 8870: BUILD America 250 Act2 reports
Lobbying firms hired
- Emergent Biosolutions Inc.$2.2M
- Cgcn Group, LLC$240K
- Capitol Counsel LLC$200K
- The Nickles Group, LLC$160K
- Alpine Group Partners, LLC.$50K
Lobbyists who worked in Congress
- Karen Stone
Legislative Director, Rep. Dina Titus (D-NV); Legislative Correspondent/Staff Assistant, Rep. Steve Israel (D-NY)…Dina Titus (D-NV)
Agencies contacted
- Senate · 50
- House Of Representatives · 42
- Health & Human Services, Dept of (Hhs) · 28
- White House Office · 24
- Office of Natl Drug Control Policy (Ndcp) · 4
- Office of Management & Budget (Omb) · 4
Related
Filings
- 2026 Q2 report$70K
- 2026 Q2 report$510K
- 2026 Q2 report$40K
- 2026 Q2 report$50K
- 2026 Q1 report$730K
From Lobbying Disclosure Act reports filed with the Senate and House.
Cite or embed this page
Capitol Receipts, “Emergent Biosolutions Inc: Lobbying Spending, Issues & Bills,” https://www.capitolreceipts.com/lobbying/cemergentbiosolutions/emergent-biosolutions-inc (accessed 2026-10-13).